CanBiotech Will Showcase A Novel Diagnostic And Prognostic Test For Diffuse, Large B-Cell Lymphoma (DLBCL) At The American Society of Hematology Annual Meeting In New Orleans
11/25/2013 9:05:08 AM
RUTHERFORD, N.J., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, is presenting data from its research collaboration with Memorial Sloan-Kettering Cancer Center ("MSKCC") at the American Society of Hematology ("ASH") 55th Annual Meeting and Exposition.
Help employers find you! Check out all the jobs and post your resume.
comments powered by